Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements.

INTRODUCTION

Speaker(s)

Gaby L. Danan, MD, PhD

• Pharmacovigilance Expert
• GLD, France

Phil Tregunno

• Head of Vigilance Operations, Safety & Surveillance
• Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom